TRAK2 and esophageal squamous cell carcinoma: Specifically, circSLC22A3 competitively bound to miR-19b-3p, thereby attenuating its inhibitory effect on Trafficking Kinesin Protein 2 (TRAK2) expression and suppressing epithelial-mesenchymal transition progression in ESCC cells, ultimately impeding metastasis.